QA: Monopar Therapeutics in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001645469_2019_Monopar_Therapeutics.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001645469')"}

Graph

Absolute values for 0001645469, Monopar Therapeutics

  xvar xval
0 AssetsCurrent 7,317,955
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 399,551
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,628,308
9 ResearchAndDevelopmentExpense 1,774,454
10 remainder_Expenses -71,615
11 remainder_Revenues 0
12 remainder_NetIncome 103,215
13 remainder_ComprehensiveNetIncome -2,396
  yvar yval
0 Assets 7,317,955
1 Liabilities 399,551
2 Expenses 3,331,147
3 Revenues 0
4 StockholdersEquity 6,918,404
5 NetIncome -3,227,932
6 ComprehensiveNetIncome -3,229,130
7 BaseVar 5,577,132
8 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time